Semaglutide (adjunct)

semaglutide · Novo Nordisk

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Semaglutide (adjunct), covering 2025-08-12 to 2025-08-12. Get the full timeline:

Most recent: Clinical Trial Update: ADJUnct Semaglutide Treatment in Type 1 Diabetes [Phase 2]